Advanced search
Publication Cover
Expert Review of Ophthalmology Volume 5, 2010 - Issue 1
Submit an article Journal homepage
366
Views
0
CrossRef citations to date
0
Altmetric
Meeting Report

Retina Congress 2009: ocular oncology

Zélia MS Corrêa Mary Knight Asbury Chair in Ophthalmic Pathology, Department of Ophthalmology, University of Cincinnati School of Medicine, 260 Stetson Street, Suite 5300, Cincinnati, OH 45267, USA. [email protected]
&
J William Harbour Paul Cibis Distinguished Professor, Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St Louis, MO, USA and 660 South Euclid Avenue/Box 8096, St Louis, MO 63110, USA. [email protected]
Pages 13-14 | Published online: 09 Jan 2014

References

  • Harbour JW. Molecular prognostic testing and individualized patient care in uveal melanoma. Am. J. Ophthalmol.148(6), 823–829.e1 (2009).
  • Halaban R, Rubin JS, Funasaka Y et al.MET and hepatocyte growth factor/scatter factor signal transduction in normal melanocytes and melanoma cells. Oncogene7(11), 2195–2206 (1992).
  • Eskelin S, Pyrhonen S, Hahka-Kemppinen M et al. A prognostic model and staging for metastatic uveal melanoma. Cancer97(2), 465–475 (2003).
  • Augsburger JJ, Correa ZM, Shaikh AH. Effectiveness of treatments for metastatic uveal melanoma. Am. J. Ophthalmol.148(1), 119–127 (2009).
  • Gragoudas ES. Proton beam irradiation of uveal melanomas: the first 30 years. The Weisenfeld Lecture. Invest. Ophthalmol. Vis. Sci.47(11), 4666–4673 (2006).
  • Char DH, Kroll S, Phillips TL, Quivey JM. Late radiation failures after iodine 125 brachytherapy for uveal melanoma compared with charged-particle (proton or helium ion) therapy. Ophthalmology109(10), 1850–1854 (2002).
  • Dunavoelgyi R, Zehetmayer M, Simader C, Schmidt-Erfurth U. Rapid improvement of radiation-induced neovascular glaucoma and exudative retinal detachment after a single intravitreal ranibizumab injection. Clin. Experiment. Ophthalmol.35(9), 878–880 (2007).
  • Abramson DH, Dunkel IJ, Brodie SE et al. A Phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results. Ophthalmology115(8), 1398–1404, 404.e1 (2008).
  • Brodie SE, Pierre Gobin Y, Dunkel IJ et al. Persistence of retinal function after selective ophthalmic artery chemotherapy infusion for retinoblastoma. Doc. Ophthalmol.119(1), 13–22 (2009).
  • Kivela T. Observed growth in small melanocytic choroidal tumors. Arch. Ophthalmol.124(4), 607–608 (2006).
  • Boutrid H, Jockovich ME, Murray TG et al. Targeting hypoxia, a novel treatment for advanced retinoblastoma. Invest. Ophthalmol. Vis. Sci.49(7), 2799–2805 (2008).
  • Sagong M, Lee J, Chang W. Application of intravitreal bevacizumab for circumscribed choroidal hemangioma. Korean J. Ophthalmol.23(2), 127–131 (2009).
  • Suri S, Banerjee R. In vitro evaluation of in situ gels as short term vitreous substitutes. J. Biomed. Mater. Res. A79(3), 650–664 (2006).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.